Skip to main content
. 2020 Jun 29;10(7):1274. doi: 10.3390/nano10071274

Figure 9.

Figure 9

Inducing anti-tumour immune responses by dendritic cell (DC) vaccination through infusing patients with ex vivo antigen loaded DCs (left) or targeting antigens and adjuvants directly to DCs in vivo (right).